Dennin R H, Husstedt W
Fortschr Med. 1983 Mar 24;101(11):482-5.
31 women were vaccinated with attenuated rubella-virus (RV) strains. According to the prevaccinal antibody status they were grouped as follows: I: HIT 1: less than 10, RV-specific IgG 1: less than 20; II: HIT 1: less than 10, RV-specific IgG 1: greater than 20; III: HIT 1: greater than or equal to 10, RV-specific IgG 1: greater than 30. The postvaccinal geometric mean titers for RV-ELISA-IgG were somewhat higher in group II compared to group I, eventually because of a weak booster effect based on low level prevaccinal RV-antibody titers--but the difference is not significant for 5%. The difference between RV-ELISA-IgG in group II and group I is significant. Within group II there is a low titer rise upon vaccination although elevated prevaccinal titers were already present. The quotient "RV-ELISA-IgG-titer: HIT-titer" is in the range of greater than or equal to 23:1 for the postvaccinal period (8-10 weeks after vaccination) compared to about 8:1 resp. in stationary sera of reconvalescent individuals. These quotients could be helpful for interpretation of suspicious elevated titers during pregnancy.
31名女性接种了减毒风疹病毒(RV)毒株。根据接种前的抗体状况,她们被分为以下几组:I组:血凝抑制试验(HIT)1:小于10,RV特异性IgG 1:小于20;II组:HIT 1:小于10,RV特异性IgG 1:大于20;III组:HIT 1:大于或等于10,RV特异性IgG 1:大于30。与I组相比,II组接种后RV-ELISA-IgG的几何平均滴度略高,最终可能是由于接种前RV抗体滴度较低导致的微弱加强效应——但5%时差异不显著。II组和I组之间RV-ELISA-IgG的差异显著。在II组中,尽管接种前滴度已经升高,但接种后滴度上升幅度较低。与恢复期个体静态血清中的约8:1相比,接种后时期(接种后8 - 10周)的“RV-ELISA-IgG滴度:HIT滴度”商在大于或等于23:1的范围内。这些商数可能有助于解释孕期可疑的升高滴度。